rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2006-3-28
|
pubmed:abstractText |
The Cambridge Risk Score (CRS) was developed to screen for type 2 diabetes mellitus risk. We assessed the ability of the CRS to predict glycosylated hemoglobin (HbA(1c)) levels and determined whether the CRS was better than body mass index (BMI) at predicting HbA(1c) levels in midlife.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0003-9926
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
166
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
682-8
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16567609-Adult,
pubmed-meshheading:16567609-Body Mass Index,
pubmed-meshheading:16567609-Diabetes Mellitus, Type 2,
pubmed-meshheading:16567609-Female,
pubmed-meshheading:16567609-Great Britain,
pubmed-meshheading:16567609-Health Surveys,
pubmed-meshheading:16567609-Hemoglobin A, Glycosylated,
pubmed-meshheading:16567609-Humans,
pubmed-meshheading:16567609-Logistic Models,
pubmed-meshheading:16567609-Male,
pubmed-meshheading:16567609-Middle Aged,
pubmed-meshheading:16567609-Obesity,
pubmed-meshheading:16567609-Predictive Value of Tests,
pubmed-meshheading:16567609-ROC Curve,
pubmed-meshheading:16567609-Risk Assessment,
pubmed-meshheading:16567609-Risk Factors,
pubmed-meshheading:16567609-Sensitivity and Specificity
|
pubmed:year |
2006
|
pubmed:articleTitle |
Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index.
|
pubmed:affiliation |
Centre for Paediatric Epidemiology and Biostatistics, Institute of Child Health, University College London, London, England. c.thomas@ich.ucl.ac.uk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|